Clinical Trials Directory

Trials / Unknown

UnknownNCT04591704

The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19

The Effect of Diabetes Mellitus on the Morbidity and Mortality Rates in Patients With COVID-19

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Uşak University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study. The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Detailed description

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study. The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19. The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Conditions

Interventions

TypeNameDescription
OTHERhospitalisation, necessity of ICU, mortality rate, lung involvementhospitalisation, necessity of ICU, mortality rate, lung involvement

Timeline

Start date
2020-03-20
Primary completion
2020-10-15
Completion
2021-07-01
First posted
2020-10-19
Last updated
2021-05-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04591704. Inclusion in this directory is not an endorsement.